Domain Venture Partners

Domain Venture Partners (DVP) is a Gibraltar-based investment firm and fund manager, primarily recognized for its strategic involvement in the generic Top-Level Domain (gTLD) market. Beyond its technology and internet infrastructure focus, the firm has been an active venture capital participant in the life sciences and biotechnology industries. DVP's healthcare investment strategy has included participating in funding rounds and acquiring interests in biopharmaceutical companies such as Antios Therapeutics, Achillion Pharmaceuticals, and Achaogen. The firm's portfolio typically focuses on innovative therapeutics for infectious diseases, rare disorders, and genetic conditions. As of 2022, the firm's primary entity, Domain Venture Partners PCC Limited, was reported to be in solvent administration.